Sort
261,768 grants matching “gene therapy”
Center for Structural Biology of HIV RNA
$5,412,171Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2024 · AI
Molecular Targets Development Program
$5,405,638James McMahon · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
(1 of 2) Genetic Epidemiology of COPD
$5,401,147James D Crapo · National Jewish Health · R01 · FY2012 · HL
SOUTHWEST REGIONAL PRIMATE RESEARCH CENTER
$5,385,227Southwest Foundation For Biomedical Res · P51 · FY2003 · RR
Transforming Research and Clinical Knowledge in Traumatic Brain Injury
$5,372,731Geoffrey T Manley · University Of California, San Francisco · U01 · FY2014 · NS
REACH: Research Enterprise to Advance a Cure for HIV
$5,371,650R. Brad Jones · Weill Medical Coll Of Cornell Univ · UM1 · FY2024 · AI
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)
$5,360,813Robert Daniel Toto · Ut Southwestern Medical Center · UL1 · FY2016 · TR
Neuropathogenesis of Retroviral Infections
$5,346,668Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Mayo Comprehensive Cancer Center Grant
$5,345,058Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2013 · CA
Gene therapy of cancer
$5,342,262Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Adoptive Cell Transfer Immunotherapy of Cancer
$5,342,262Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Improving identification and healthcare for patients with Inherited Cancer Syndromes: Evidence-based EMR implementation using a web-based computer platform
$5,339,027Georgia L Wiesner · Vanderbilt University Medical Center · U01 · FY2019 · CA
HOPE - HIV Obstruction by Programmed Epigenetics
$5,336,026Melanie Maria Ott · J. David Gladstone Institutes · UM1 · FY2024 · AI
HOPE - HIV Obstruction by Programmed Epigenetics
$5,336,026Melanie Maria Ott · J. David Gladstone Institutes · UM1 · FY2021 · AI
HOPE - HIV Obstruction by Programmed Epigenetics
$5,336,026Melanie Maria Ott · J. David Gladstone Institutes · UM1 · FY2022 · AI
BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication
$5,334,612Douglas F Nixon · George Washington University · UM1 · FY2017 · AI
DCTD Biopharmaceutical Development
$5,333,006David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
Integrative translational discovery of vascular risk factors in aging and dementia
$5,327,310Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · RF1 · FY2015 · AG
Cancer Center Support Grant
$5,317,547Michael A Teitell · University Of California Los Angeles · P30 · FY2025 · CA
THE UNIVERSITY OF PENNSYLVANIA CANCER CENTER CORE GRANT
$5,315,570University Of Pennsylvania · P30 · FY2003 · CA
FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.
$5,308,961Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic
$5,305,044Jeffrey S Glenn · Stanford University · U19 · FY2014 · AI
Discovery of novel Henipavirus inhibitors
$5,291,771Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2022 · AI
Multiscale analysis of influenza host-pathogen interactions: Fluomics
$5,286,096Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease
$5,279,327Howard Feldman · University Of California, San Diego · R01 · FY2019 · AG